The global Sanger sequencing service market is experiencing robust growth due to the increasing demand for accurate DNA sequencing technologies in clinical diagnostics, pharmaceutical research, biotechnology, and academic studies. Sanger sequencing remains one of the most reliable methods for validating genetic variations, mutation detection, and targeted sequencing applications.
The Sanger sequencing service market size is projected to reach US$ 2,292.71 million by 2031 from US$ 841.62 million in 2023. The market is expected to register a CAGR of 13.3% during 2023–2031.
The growing adoption of precision medicine, rising prevalence of genetic disorders, and increasing investments in genomics research are major factors driving market growth. In addition, advancements in sequencing workflows and the expansion of personalized healthcare are creating new opportunities for service providers worldwide.
Increasing Demand for Genetic Testing and Precision Medicine
The rising importance of genetic testing in disease diagnosis and treatment planning is significantly boosting the demand for sequencing services. Healthcare providers are increasingly using genetic analysis to identify inherited disorders, cancer mutations, and rare diseases. Sanger sequencing continues to play a vital role in confirming results generated through next-generation sequencing platforms.
Get Sample PDF - https://www.theinsightpartners.com/sample/TIPRE00007514
Precision medicine initiatives across developed and emerging economies are also accelerating market expansion. Researchers and clinicians rely on accurate sequencing methods to develop targeted therapies and personalized treatment approaches based on individual genetic profiles.
The pharmaceutical and biotechnology sectors are increasingly utilizing sequencing services for drug discovery, biomarker identification, and clinical trial analysis. This growing application base is expected to support long-term market growth.
Role of Sanger Sequencing in Research and Diagnostics
Sanger sequencing remains widely recognized for its high accuracy, reproducibility, and reliability in targeted sequencing applications. Despite the emergence of advanced sequencing technologies, it continues to serve as a gold standard for validating DNA sequences and identifying mutations.
Research institutions and academic laboratories extensively use sequencing services for gene analysis, microbial identification, evolutionary biology studies, and molecular diagnostics. The technology is particularly valuable in small-scale sequencing projects where precise and dependable results are essential.
Clinical laboratories are increasingly integrating sequencing services into routine diagnostic workflows to support oncology testing, prenatal screening, and infectious disease analysis. The ability to deliver accurate sequence data with minimal errors continues to strengthen the relevance of this technology in modern healthcare.
Technological Advancements Supporting Market Growth
Continuous improvements in sequencing chemistry, automation, and data analysis software are enhancing the efficiency of sequencing services. Automated capillary electrophoresis systems and advanced bioinformatics tools are reducing turnaround times and improving overall workflow productivity.
Service providers are focusing on delivering high-throughput sequencing solutions while maintaining exceptional data quality. Integration of cloud-based data management platforms and artificial intelligence-assisted analysis is further streamlining sequencing operations.
In addition, the growing availability of customized sequencing services tailored to specific research requirements is attracting a broader customer base. Laboratories and research organizations increasingly prefer outsourced sequencing services to reduce infrastructure costs and improve operational flexibility.
Expanding Applications Across Industries
The applications of sequencing services extend across several industries, contributing to sustained market demand.
Healthcare and Clinical Diagnostics
Healthcare organizations use sequencing services for mutation analysis, hereditary disease screening, cancer research, and pathogen identification. Increasing awareness regarding early disease detection is driving adoption in clinical settings.
Pharmaceutical and Biotechnology Industry
Pharmaceutical companies utilize sequencing technologies in drug development, vaccine research, and biomarker discovery. Biotechnology firms are also investing in genomics-based research to support innovation in therapeutics and diagnostics.
Academic and Research Institutions
Universities and research centers rely on sequencing services for genomic studies, molecular biology research, and genetic engineering projects. Growing funding for life science research is expected to further increase service demand.
Agricultural and Environmental Research
Sequencing technologies are increasingly used in agricultural biotechnology, plant genetics, and environmental monitoring applications. Researchers use sequencing analysis to study biodiversity, microbial ecosystems, and crop improvement strategies.
Key Market Drivers
Several factors are contributing to the rapid growth of the global market:
- Rising prevalence of genetic and chronic diseases
- Increasing demand for personalized medicine
- Growth in genomics and molecular biology research
- Expansion of pharmaceutical and biotechnology industries
- Technological advancements in sequencing workflows
- Increasing adoption of outsourced laboratory services
- Growing applications in oncology and infectious disease diagnostics
Government support for genomics initiatives and increasing healthcare investments are also expected to create favorable growth opportunities during the forecast period.
Regional Analysis
North America holds a significant share of the global market due to advanced healthcare infrastructure, strong presence of biotechnology companies, and high investments in genomics research. The region also benefits from increasing adoption of precision medicine and molecular diagnostics.
Europe represents another prominent market driven by expanding research activities, rising healthcare expenditure, and increasing focus on genetic disease diagnosis. Regulatory support for genomic testing is further contributing to regional growth.
The Asia Pacific region is anticipated to witness substantial expansion over the forecast period. Countries such as China, India, and Japan are investing heavily in biotechnology research, healthcare modernization, and genomic medicine. The growing number of research laboratories and increasing awareness regarding genetic testing are expected to accelerate market development in the region.
Competitive Landscape
The market is characterized by the presence of several global and regional service providers focusing on technological innovation, service expansion, and strategic collaborations. Companies are investing in advanced sequencing platforms and expanding their laboratory capabilities to strengthen market presence.
Top Players in the Market
- Thermo Fisher Scientific
- Eurofins Scientific
- Azenta Life Sciences
- GENEWIZ
- Microsynth
- Source BioScience
- Quintara Biosciences
- Fasteris SA
- Macrogen Inc.
- Eton Bioscience Inc.
Future Outlook
The future of the global Sanger sequencing service industry appears highly promising as genomic research and precision medicine continue to evolve. Increasing demand for accurate mutation validation and targeted genetic analysis will sustain the relevance of sequencing services despite advancements in next-generation technologies.
The integration of automation, artificial intelligence, and advanced bioinformatics platforms is expected to improve sequencing efficiency and data interpretation capabilities. Expanding applications in oncology, rare disease diagnostics, infectious disease monitoring, and pharmacogenomics will further support market growth through 2031.
Growing collaborations between healthcare providers, research institutions, and biotechnology companies are likely to accelerate innovation and service adoption. As genomic medicine becomes increasingly integrated into mainstream healthcare, sequencing services are expected to remain an essential component of molecular diagnostics and life science research worldwide.
Top Trending Reports:
DNA Sequencing Electrophoresis System Market
About Us
The Insight Partners is a leading market research and consulting firm delivering actionable insights through in-depth industry analysis and strategic intelligence. The firm supports clients across various industries in making informed business decisions by providing comprehensive market forecasts, competitive assessments, and growth opportunities.
Contact Us
The Insight Partners
Email: sales@theinsightpartners.com
Phone: +1-646-491-9876
Website: www.theinsightpartners.com
Also Available in: Korean German Japanese French Chinese Italian Spanish
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt